These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 33209754)

  • 1. COVID 19 and diabetes: An endocrinologist's perspective.
    Behera KK; Hota D; Mahapatra A
    J Family Med Prim Care; 2020 Sep; 9(9):4512-4515. PubMed ID: 33209754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome.
    Lin F; Ichim TE; Pingle S; Jones LD; Kesari S; Ashili S
    World J Stem Cells; 2020 Oct; 12(10):1067-1079. PubMed ID: 33178392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and diabetes mellitus: Unraveling the hypotheses that worsen the prognosis (Review).
    Albulescu R; Dima SO; Florea IR; Lixandru D; Serban AM; Aspritoiu VM; Tanase C; Popescu I; Ferber S
    Exp Ther Med; 2020 Dec; 20(6):194. PubMed ID: 33101484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19.
    Douedi S; Chaudhri M; Miskoff J
    Ann Thorac Med; 2020; 15(3):171-173. PubMed ID: 32831940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
    Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S
    Inflamm Regen; 2020; 40():14. PubMed ID: 32582401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic Ketoacidosis in Coronavirus Disease Patients With Type 2 Diabetes Mellitus.
    Winn SP; Oo ZT; Htun NN; Soe MHP; Aung MM
    Cureus; 2020 Aug; 12(8):e9731. PubMed ID: 32953287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
    Valencia I; Peiró C; Lorenzo Ó; Sánchez-Ferrer CF; Eckel J; Romacho T
    Front Pharmacol; 2020; 11():1161. PubMed ID: 32848769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple potential targets of opioids in the treatment of acute respiratory distress syndrome from COVID-19.
    Cismaru CA; Cismaru GL; Nabavi SF; Ghanei M; Burz CC; Nabavi SM; Berindan Neagoe I
    J Cell Mol Med; 2021 Jan; 25(1):591-595. PubMed ID: 33211389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study.
    Bozzi G; Mangioni D; Minoia F; Aliberti S; Grasselli G; Barbetta L; Castelli V; Palomba E; Alagna L; Lombardi A; Ungaro R; Agostoni C; Baldini M; Blasi F; Cesari M; Costantino G; Fracanzani AL; Montano N; Monzani V; Pesenti A; Peyvandi F; Sottocorno M; Muscatello A; Filocamo G; Gori A; Bandera A
    J Allergy Clin Immunol; 2021 Feb; 147(2):561-566.e4. PubMed ID: 33220354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of glycosylated hemoglobin and outcomes in patients with COVID-19 and pre-existing type 2 diabetes: A protocol for systematic review and meta-analysis.
    Zhang N; Yun R; Liu L; Yang L
    Medicine (Baltimore); 2020 Nov; 99(47):e23392. PubMed ID: 33217883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions.
    Meyerowitz EA; Sen P; Schoenfeld SR; Neilan TG; Frigault MJ; Stone JH; Kim AY; Mansour MK
    Clin Infect Dis; 2021 Jun; 72(12):e1130-e1143. PubMed ID: 33216852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis.
    Bud ES; Vlasa A; Bud A
    Arch Med Res; 2021 Apr; 52(3):356. PubMed ID: 33220933
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenotypic Characteristics and Development of a Hospitalization Prediction Risk Score for Outpatients with Diabetes and COVID-19: The DIABCOVID Study.
    Lasbleiz A; Cariou B; Darmon P; Soghomonian A; Ancel P; Boullu S; Houssays M; Romain F; Lagier JC; Boucekine M; Resseguier N; Gourdy P; Pichelin M; Wargny M; Dutour A; Gaborit B
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33233575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study.
    Sinha P; Jafarzadeh SR; Assoumou SA; Bielick CG; Carpenter B; Garg S; Harleen S; Neogi T; Nishio MJ; Sagar M; Sharp V; Kissin EY
    J Infect Dis; 2021 Feb; 223(4):581-588. PubMed ID: 33216906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.
    Lu L; Zhang H; Dauphars DJ; He YW
    Trends Immunol; 2021 Jan; 42(1):3-5. PubMed ID: 33214057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi-Organ Failure.
    Uckun FM; Carlson J; Orhan C; Powell J; Pizzimenti NM; van Wyk H; Ozercan IH; Volk M; Sahin K
    Front Pharmacol; 2020; 11():594321. PubMed ID: 33244300
    [No Abstract]   [Full Text] [Related]  

  • 17. Routine laboratory testing to determine if a patient has COVID-19.
    Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhinovirus and asthma: Challenges and opportunities.
    Ortega H; Nickle D; Carter L
    Rev Med Virol; 2021 Jul; 31(4):e2193. PubMed ID: 33217098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological therapies against COVID-19 : state of the art, between hopes and disappointments].
    Scheen AJ; Moutschen M
    Rev Med Liege; 2020 Sup; 75(S1):162-169. PubMed ID: 33211441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and COVID-19: a major challenge in pandemic period?
    Chakraborty C; Sharma AR; Bhattacharya M; Sharma G; Agoramoorthy G; Lee SS
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11409-11420. PubMed ID: 33215463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.